BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of 28.75 billion. The enterprise value is 27.21 billion.
| Market Cap | 28.75B |
| Enterprise Value | 27.21B |
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.86% |
| Shares Change (QoQ) | +1.23% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 74.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 8.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -42.19 |
| EV / Sales | 7.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -42.96 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.80 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.71 |
| Interest Coverage | -38.61 |
Financial Efficiency
Return on equity (ROE) is -18.77% and return on invested capital (ROIC) is -8.01%.
| Return on Equity (ROE) | -18.77% |
| Return on Assets (ROA) | -6.07% |
| Return on Invested Capital (ROIC) | -8.01% |
| Return on Capital Employed (ROCE) | -15.35% |
| Revenue Per Employee | 346,386 |
| Profits Per Employee | -58,617 |
| Employee Count | 11,000 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.30 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.42% in the last 52 weeks. The beta is 0.65, so BeiGene's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +38.42% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 57.54 |
| Average Volume (20 Days) | 531 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.69 |
Income Statement
In the last 12 months, BeiGene had revenue of 3.81 billion and -644.79 million in losses. Loss per share was -6.12.
| Revenue | 3.81B |
| Gross Profit | 3.22B |
| Operating Income | -569.01M |
| Pretax Income | -533.00M |
| Net Income | -644.79M |
| EBITDA | -401.98M |
| EBIT | -569.01M |
| Loss Per Share | -6.12 |
Balance Sheet
The company has 2.63 billion in cash and 1.08 billion in debt, giving a net cash position of 1.55 billion.
| Cash & Cash Equivalents | 2.63B |
| Total Debt | 1.08B |
| Net Cash | 1.55B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.33B |
| Book Value Per Share | 31.22 |
| Working Capital | 1.78B |
Cash Flow
In the last 12 months, operating cash flow was -140.63 million and capital expenditures -492.66 million, giving a free cash flow of -633.29 million.
| Operating Cash Flow | -140.63M |
| Capital Expenditures | -492.66M |
| Free Cash Flow | -633.29M |
| FCF Per Share | n/a |
Margins
Gross margin is 84.41%, with operating and profit margins of -14.93% and -16.92%.
| Gross Margin | 84.41% |
| Operating Margin | -14.93% |
| Pretax Margin | -13.99% |
| Profit Margin | -16.92% |
| EBITDA Margin | -10.55% |
| EBIT Margin | -14.93% |
| FCF Margin | n/a |
Dividends & Yields
BeiGene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.86% |
| Shareholder Yield | -0.86% |
| Earnings Yield | -2.24% |
| FCF Yield | -2.20% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BeiGene has an Altman Z-Score of 2.93. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.93 |
| Piotroski F-Score | n/a |